Viewing Study NCT06503692


Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2026-03-01 @ 3:54 PM
Study NCT ID: NCT06503692
Status: RECRUITING
Last Update Posted: 2025-01-09
First Post: 2024-07-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Scoring Balloon and High Pressure Balloon in the Treatment of Arteriovenous Graft Stenosis
Sponsor: DK Medical Technology (Suzhou) Co., Ltd.
Organization:

Study Overview

Official Title: A Multicentre, Randomized Controlled Clinical Trial of Scoring Balloon Versus High Pressure Balloon in the Treatment of Arteriovenous Graft Stenosis
Status: RECRUITING
Status Verified Date: 2025-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DKTAVG
Brief Summary: This is a multicenter, prospective, randomized controlled clinical study. Patients with hemodialysis arteriovenous graft fistula stenosis will be recruited to explore whether the scoring balloon is superior to the high pressure balloon in treating such lesions, so as to provide a basis for optimizing the treatment of such lesions.

This study will be conducted in seven (7) clinical trial institutions, with a total of 140 subjects included. After randomization, the subjects will use either the scoring balloon dilatation catheter, developed and produced by DK Medical Technology Co., Ltd., or the peripheral balloon dilatation catheter for surgical treatment. Clinical follow-up will be carried out within 5 days, 3 months, 6 months, and 12 months after the procedure.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: